Single-cell atlas of a non-human primate reveals new pathogenic 1 mechanisms of COVID-19 2

Stopping COVID-19 is a priority worldwide. Understanding which cell types are targeted by 51 SARS-CoV-2 virus, whether interspecies differences exist, and how variations in cell state 52 influence viral entry is fundamental for accelerating therapeutic and preventative 53 approaches. In this endeavor, we profiled the transcriptome at single-cell resolution of nine 54 tissues from a Macaca fascicularis monkey. The distribution of SARS-CoV-2 facilitators, ACE2 55 and TMRPSS2, in different cell subtypes showed substantial heterogeneity across lung, 56 kidney, thyroid and liver. Co-expression analysis identified immunomodulatory proteins such 57 as IDO2 and ANPEP as potential SARS-CoV-2 targets responsible for immune cell exhaustion. 58 Furthermore, single-cell chromatin accessibility analysis of the kidney unveiled a plausible link 59 between IL6-mediated innate immune responses aiming to protect tissue and enhanced ACE2 60 expression that could promote viral entry. Our work constitutes a unique resource for 61 understanding SARS-CoV-2 pathophysiology in two phylogenetically close species, which 62 might guide in the development of effective treatments in humans.

[1]  Dan Zhang,et al.  Construction of a human cell landscape at single-cell level , 2020, Nature.

[2]  K. Shi,et al.  Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.

[3]  B. Young,et al.  COVID-19 in gastroenterology: a clinical perspective , 2020, Gut.

[4]  Gianpaolo Ronconi,et al.  Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. , 2020 .

[5]  Chuan Qin,et al.  Reinfection could not occur in SARS-CoV-2 infected rhesus macaques , 2020 .

[6]  D. Wang,et al.  The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.

[7]  V. Jha,et al.  The Novel Coronavirus 2019 epidemic and kidneys , 2020, Kidney International.

[8]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[9]  Taojiao Wang,et al.  Caution on Kidney Dysfunctions of COVID-19 Patients , 2020, medRxiv.

[10]  Suxin Wan,et al.  Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) , 2020, medRxiv.

[11]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[12]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[13]  Ricardo J. Miragaia,et al.  scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation , 2019, Genome Biology.

[14]  Zhifeng Wang,et al.  A portable and cost-effective microfluidic system for massively parallel single-cell transcriptome profiling , 2019, bioRxiv.

[15]  Sarah A. Teichmann,et al.  Spatiotemporal immune zonation of the human kidney , 2019, Science.

[16]  Dominic Grün,et al.  A Human Liver Cell Atlas reveals Heterogeneity and Epithelial Progenitors , 2019, Nature.

[17]  Trygve E Bakken,et al.  Single-nucleus and single-cell transcriptomes compared in matched cortical cell types , 2018, PloS one.

[18]  Zhènglì Shí,et al.  Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.

[19]  S. Orkin,et al.  Mapping the Mouse Cell Atlas by Microwell-Seq , 2018, Cell.

[20]  Fabian J Theis,et al.  SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.

[21]  M. Serrano,et al.  Senescence promotes in vivo reprogramming through p16INK 4a and IL‐6 , 2017, Aging cell.

[22]  R. Carey,et al.  Renal Collectrin Protects against Salt-Sensitive Hypertension and Is Downregulated by Angiotensin II. , 2017, Journal of the American Society of Nephrology : JASN.

[23]  Yan Li,et al.  SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation , 2016, PloS one.

[24]  S. Reichenbach,et al.  Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial , 2016, The Lancet.

[25]  G. Gao,et al.  Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses , 2016, Trends in Microbiology.

[26]  A. Omrani,et al.  Middle East respiratory syndrome , 2015, Canadian Medical Association Journal.

[27]  Jae Wook Lee,et al.  Deep Sequencing in Microdissected Renal Tubules Identifies Nephron Segment-Specific Transcriptomes. , 2015, Journal of the American Society of Nephrology : JASN.

[28]  D. Fuchs,et al.  Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection , 2015, Journal of Innate Immunity.

[29]  Edwin Cuppen,et al.  Sambamba: fast processing of NGS alignment formats , 2015, Bioinform..

[30]  A. Butte,et al.  Immune response profiling identifies autoantibodies specific to Moyamoya patients , 2013, Orphanet Journal of Rare Diseases.

[31]  Lei Yu,et al.  Abnormal expression and dysfunction of novel SGLT2 mutations identified in familial renal glucosuria patients , 2011, Human Genetics.

[32]  P. Nelson,et al.  Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease , 2006, Molecular and Cellular Biology.

[33]  S. Perlman,et al.  ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia , 2005, Journal of Virology.

[34]  Kwok-Hung Chan,et al.  Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[36]  N. Hooper,et al.  ACE2: from vasopeptidase to SARS virus receptor , 2004, Trends in Pharmacological Sciences.

[37]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[38]  K. Holmes,et al.  Molecular Determinants of Species Specificity in the Coronavirus Receptor Aminopeptidase N (CD13): Influence of N-Linked Glycosylation , 2001, Journal of Virology.

[39]  W. Bartsch,et al.  The surfactant system of the adult lung: physiology and clinical perspectives , 1992, The clinical investigator.

[40]  B. Delmas,et al.  Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV , 1992, Nature.

[41]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[42]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[43]  A. Birn Searching for the source , 2011, Nature Medicine.

[44]  R. Santer,et al.  Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. , 2010, American Society of Nephrology. Clinical Journal.

[45]  R. Mason,et al.  Type II alveolar cell. Defender of the alveolus. , 1977, The American review of respiratory disease.

[46]  transmission of , 2022 .